Diabetes Devices Market Size & Share, by Type (Blood Glucose Monitoring, Insulin Delivery Devices); Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinics, Online Pharmacy); End-user (Diagnostic Center, Hospitals, Home Care) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4642
  • Published Date: Jan 30, 2023
  • Report Format: PDF, PPT

Companies Dominating the Diabetes Devices Landscape

top-features-companies
    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott Laboratories
    • ARKRAY, Inc.
    • Bayer AG
    • Lifescan, Inc.
    • B. Braun Melsungen AG
    • Dexcom, Inc.
    • Insulet Corporation
    • Ypsomed AG
    • Sanofi

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • LifeScan IP Holdings, LLC declared the launch of U.S OneTouch Verio Reflect, the first product with a Blood Sugar Mentor. This feature allows people with diabetes a personalized real-time guide.

  • Insulet Corporation declared that it’s Omnipod 5 Automated Insulin Delivery System received clearance from the U.S Food and Drug Administration. This was used for 6 years and older people suffering from type 1 diabetes.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4642
  • Published Date: Jan 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising diabetes cases and the growing obese population across the world are the major factors driving the growth of the diabetes devices market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 – 2033.

Lack of knowledge to operate devices and the presence of side effects are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Medtronic plc, Abbott Laboratories, Arkray, Inc., Bayer AG, Lifescan, Inc., B. Braun Melsungen AG, Dexcom, Inc., Insulet Corporation, Ypsomed AG, Sanofi.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, distribution channel, end-user, and by region.

The insulin delivery devices segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying